{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T03:09:14Z","timestamp":1794107354145,"version":"4.8.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T00:00:00Z","timestamp":1680220800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Survival after pancreaticoduodenectomy (PD) for pancreatic ductal adenocarcinoma (PDAC) remains poor because of high incidences of recurrence. The risk factors, patterns, and long-term prognosis in patients with early recurrence and late recurrence (ER and LR) for PDAC after PD were studied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Data from patients who underwent PD for PDAC were analyzed. Recurrence was divided into ER (ER \u22641 years) and LR (LR &gt;1 years) using the time to recurrence after surgery. Characteristics and patterns of initial recurrence, and postrecurrence survival (PRS) were compared between patients with ER and LR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Among the 634 patients, 281 (44.3%) and 249 (39.3%) patients developed ER and LR, respectively. In the multivariate analysis, preoperative CA19-9 levels, resection margin status, and tumor differentiation were significantly associated with both ER and LR, while lymph node metastasis and perineal invasion were associated with LR. Patients with ER, when compared with patients with LR, showed a significantly higher proportion of liver-only recurrence (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.05), and worse median PRS (5.2 vs. 9.3 months,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001). Lung-only recurrence had a significantly longer PRS when compared with liver-only recurrence (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001). Multivariate analysis demonstrated that ER and irregular postoperative recurrence surveillance were independently associated with a worse prognosis (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The risk factors for ER and LR after PD are different for PDAC patients. Patients who developed ER had worse PRS than those who developed LR. Patients with lung-only recurrence had a significantly better prognosis than those with other recurrent sites.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000000296","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T09:01:14Z","timestamp":1680253274000},"page":"785-793","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":49,"title":["Early and late recurrence patterns of pancreatic ductal adenocarcinoma after pancreaticoduodenectomy: a multicenter study"],"prefix":"10.1097","volume":"109","author":[{"given":"Xiu-Ping","family":"Zhang","sequence":"first","affiliation":[{"name":"Medical School of Chinese People\u2019s Liberation Army (PLA), Faculty of Hepato-Biliary-Pancreatic Surgery, The First Medical Center of Chinese PLA General Hospital, Beijing"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Liver Transplantation and Hepatobiliary Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Xing","family":"Gao","sequence":"additional","affiliation":[{"name":"Medical School of Chinese People\u2019s Liberation Army (PLA), Faculty of Hepato-Biliary-Pancreatic Surgery, The First Medical Center of Chinese PLA General Hospital, Beijing"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Ming","family":"Zhao","sequence":"additional","affiliation":[{"name":"Medical School of Chinese People\u2019s Liberation Army (PLA), Faculty of Hepato-Biliary-Pancreatic Surgery, The First Medical Center of Chinese PLA General Hospital, Beijing"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Dong","family":"Zhao","sequence":"additional","affiliation":[{"name":"Medical School of Chinese People\u2019s Liberation Army (PLA), Faculty of Hepato-Biliary-Pancreatic Surgery, The First Medical Center of Chinese PLA General Hospital, Beijing"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Gen","family":"Hu","sequence":"additional","affiliation":[{"name":"Medical School of Chinese People\u2019s Liberation Army (PLA), Faculty of Hepato-Biliary-Pancreatic Surgery, The First Medical Center of Chinese PLA General Hospital, Beijing"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Long","family":"Tan","sequence":"additional","affiliation":[{"name":"Medical School of Chinese People\u2019s Liberation Army (PLA), Faculty of Hepato-Biliary-Pancreatic Surgery, The First Medical Center of Chinese PLA General Hospital, Beijing"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan Yee","family":"Lau","sequence":"additional","affiliation":[{"name":"Medical School of Chinese People\u2019s Liberation Army (PLA), Faculty of Hepato-Biliary-Pancreatic Surgery, The First Medical Center of Chinese PLA General Hospital, Beijing"},{"name":"Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5170-6474","authenticated-orcid":false,"given":"Rong","family":"Liu","sequence":"additional","affiliation":[{"name":"Medical School of Chinese People\u2019s Liberation Army (PLA), Faculty of Hepato-Biliary-Pancreatic Surgery, The First Medical Center of Chinese PLA General Hospital, Beijing"},{"name":"Department of Liver Transplantation and Hepatobiliary Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,4]]},"reference":[{"key":"R1-20250824","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R2-20250824","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1245\/s10434-008-0295-2","article-title":"Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma","volume":"16","author":"Katz","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"R3-20250824","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1245\/s10434-018-6558-7","article-title":"Implications of the pattern of disease recurrence on survival following pancreatectomy for pancreatic ductal adenocarcinoma","volume":"25","author":"Groot","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"R4-20250824","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.ejso.2008.12.006","article-title":"Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma","volume":"35","author":"Van den Broeck","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"R5-20250824","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.surg.2020.06.042","article-title":"Recurrence patterns and postrecurrence survival after curative intent resection for pancreatic ductal adenocarcinoma","volume":"169","author":"Kolbeinsson","year":"2021","journal-title":"Surgery"},{"key":"R6-20250824","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0140-6736(16)00141-0","article-title":"Pancreatic cancer","volume":"388","author":"Kamisawa","year":"2016","journal-title":"Lancet"},{"key":"R7-20250824","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3390\/cancers12010137","article-title":"Predictive nomogram for early recurrence after pancreatectomy in resectable pancreatic cancer: risk classification using preoperative clinicopathologic factors","volume":"12","author":"Kim","year":"2020","journal-title":"Cancers (Basel)"},{"key":"R8-20250824","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.3390\/cancers13102285","article-title":"Perioperative predictors of early recurrence for resectable and borderline-resectable pancreatic cancer","volume":"13","author":"Imamura","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R9-20250824","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12957-016-1078-z","article-title":"Preoperative predictors for early recurrence of resectable pancreatic cancer","volume":"15","author":"Nishio","year":"2017","journal-title":"World J Surg Oncol"},{"key":"R10-20250824","doi-asserted-by":"crossref","first-page":"e1541","DOI":"10.1634\/theoncologist.2019-0944","article-title":"Early and late recurrence of hepatitis b virus-associated hepatocellular carcinoma","volume":"25","author":"Wang","year":"2020","journal-title":"Oncologist"},{"key":"R11-20250824","doi-asserted-by":"crossref","first-page":"106165","DOI":"10.1016\/j.ijsu.2021.106165","article-title":"STROCSS 2021: strengthening the reporting of cohort, cross-sectional and case-control studies in surgery","volume":"96","author":"Mathew","year":"2021","journal-title":"Int J Surg"},{"key":"R12-20250824","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/01.sla.0000217673.04165.ea","article-title":"One thousand consecutive pancreaticoduodenectomies","volume":"244","author":"Cameron","year":"2006","journal-title":"Ann Surg"},{"issue":"1","key":"R13-20250824","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/SLA.0000000000003190","article-title":"Practice patterns and perioperative outcomes of laparoscopic pancreaticoduodenectomy in China: a retrospective multicenter analysis of 1029 patients","volume":"273","author":"Wang","year":"2021","journal-title":"Ann Surg"},{"key":"R14-20250824","doi-asserted-by":"crossref","first-page":"e1277","DOI":"10.1097\/SLA.0000000000003664","article-title":"Learning curve from 450 cases of robot-assisted pancreaticoduocectomy in a high-volume pancreatic center: optimization of operative procedure and a retrospective study","volume":"274","author":"Shi","year":"2021","journal-title":"Ann Surg"},{"key":"R15-20250824","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/SLA.0000000000002234","article-title":"Patterns, timing, and predictors of recurrence following pancreatectomy for pancreatic ductal adenocarcinoma","volume":"267","author":"Groot","year":"2018","journal-title":"Ann Surg"},{"key":"R16-20250824","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/jamasurg.2018.4334","article-title":"Risk factors, patterns, and outcomes of late recurrence after liver resection for hepatocellular carcinoma: a multicenter study from China","volume":"154","author":"Xu","year":"2019","journal-title":"JAMA Surg"},{"key":"R17-20250824","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s10147-021-02067-8","article-title":"Avelumab first-line maintenance plus best supportive care (BSC) vs BSC alone for advanced urothelial carcinoma: JAVELIN Bladder 100 Japanese subgroup analysis","volume":"27","author":"Tomita","year":"2022","journal-title":"Int J Clin Oncol"},{"key":"R18-20250824","first-page":"659","article-title":"Concepts and definitions for \u201csupportive care,\u201d \u201cbest supportive care,\u201d \u201cpalliative care,\u201d and \u201chospice care\u201d in the published literature, dictionaries, and textbooks","volume":"21","author":"Hui","year":"2013","journal-title":"Support Care Cancer"},{"key":"R19-20250824","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1159\/000494382","article-title":"Predictive early recurrence factors of preoperative clinicophysiological findings in pancreatic cancer","volume":"59","author":"Suzuki","year":"2018","journal-title":"Eur Surg Res"},{"key":"R20-20250824","doi-asserted-by":"crossref","first-page":"18634","DOI":"10.1038\/s41598-019-55016-x","article-title":"Developing a preoperative serum metabolome-based recurrence-predicting nomogram for patients with resected pancreatic ductal adenocarcinoma","volume":"9","author":"Rho","year":"2019","journal-title":"Sci Rep"},{"key":"R21-20250824","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa032295","article-title":"A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer","volume":"350","author":"Neoptolemos","year":"2004","journal-title":"N Engl J Med"},{"key":"R22-20250824","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1245\/s10434-017-6134-6","article-title":"Stereotactic body radiation therapy for isolated local recurrence after surgical resection of pancreatic ductal adenocarcinoma appears to be safe and effective","volume":"25","author":"Ryan","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"R23-20250824","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff","year":"2013","journal-title":"N Engl J Med"},{"key":"R24-20250824","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1245\/ASO.2005.05.028","article-title":"Feasibility and efficacy of combination therapy with preoperative and postoperative chemoradiation, extended pancreatectomy, and postoperative liver perfusion chemotherapy for locally advanced cancers of the pancreatic head","volume":"12","author":"Ohigashi","year":"2005","journal-title":"Ann Surg Oncol"},{"key":"R25-20250824","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/ijc.33744","article-title":"Pan-cancer analysis of prognostic metastatic phenotypes","volume":"150","author":"Zaorsky","year":"2022","journal-title":"Int J Cancer"},{"key":"R26-20250824","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.1111\/jcmm.16573","article-title":"Development and validation of glycolysis-related prognostic score for prediction of prognosis and chemosensitivity of pancreatic ductal adenocarcinoma","volume":"25","author":"Zhang","year":"2021","journal-title":"J Cell Mol Med"},{"key":"R27-20250824","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1097\/SLA.0000000000002734","article-title":"Defining and predicting early recurrence in 957 patients with resected pancreatic ductal adenocarcinoma","volume":"269","author":"Groot","year":"2019","journal-title":"Ann Surg"},{"key":"R28-20250824","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/MPA.0000000000001066","article-title":"A therapeutic strategy for resectable pancreatic cancer based on risk factors of early recurrence","volume":"47","author":"Kurahara","year":"2018","journal-title":"Pancreas"},{"key":"R29-20250824","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41421-021-00271-4","article-title":"Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel fibroblast subtype associated with poor prognosis but better immunotherapy response","volume":"7","author":"Wang","year":"2021","journal-title":"Cell Discov"},{"key":"R30-20250824","doi-asserted-by":"crossref","first-page":"103315","DOI":"10.1016\/j.ebiom.2021.103315","article-title":"Single-cell RNA-seq reveals dynamic change in tumor microenvironment during pancreatic ductal adenocarcinoma malignant progression","volume":"66","author":"Chen","year":"2021","journal-title":"EBioMedicine"},{"key":"R31-20250824","doi-asserted-by":"crossref","first-page":"659987","DOI":"10.3389\/fonc.2021.659987","article-title":"Clinical effects of stereotactic body radiation therapy targeting the primary tumor of liver-only oligometastatic pancreatic cancer","volume":"11","author":"Ji","year":"2021","journal-title":"Front Oncol"},{"key":"R32-20250824","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S1470-2045(21)00286-2","article-title":"Stereotactic body radiotherapy plus pembrolizumab and trametinib versus stereotactic body radiotherapy plus gemcitabine for locally recurrent pancreatic cancer after surgical resection: an open-label, randomised, controlled, phase 2 trial","volume":"22","author":"Zhu","year":"2021","journal-title":"Lancet Oncol"},{"key":"R33-20250824","first-page":"343","article-title":"Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience from two institutions","volume":"4","author":"Wild","year":"2013","journal-title":"J Gastrointest Oncol"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000000296","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T19:04:29Z","timestamp":1756062269000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000000296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,31]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000000296","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,31]]},"assertion":[{"value":"2022-10-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-31","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}